Skip to main content

Month: June 2023

POET Technologies Announces Sample Availability of “POET Infinity” and Testing with Two Lead Customers

Alpha samples of the chiplet-based transmitter platform for 400G, 800G and 1.6T data center solutions are ready for shipment TORONTO, June 14, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, telecommunication and artificial intelligence markets, today announced alpha sample readiness of “POET Infinity™”, a chiplet-based transmitter platform for 400G, 800G and 1.6T pluggable transceivers and co-packaged optics solutions. Two lead customers have agreed to partner with POET to test the alpha version of the Infinity chiplet. The POET Infinity chiplet complements the POET 800G 2xFR4 Receiver optical engine that the Company announced in February 2023,...

Continue reading

Ventyx Biosciences Announces Initiation of Dosing in a Phase 1 Trial of VTX3232, a Novel CNS-Penetrant NLRP3 Inhibitor

Topline data from the Phase 1 SAD/MAD trial of VTX3232 are expected in H1 2024 ENCINITAS, Calif., June 14, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that the first subject has been dosed in a Phase 1 trial of VTX3232, a novel central nervous system (CNS)-penetrant NLRP3 inhibitor. “VTX3232 is our fourth internally discovered compound to enter the clinic and an exciting addition to our broad, wholly-owned clinical-stage pipeline of orally-delivered small molecules targeting large disease populations with high unmet need,” said Raju Mohan, Chief Executive Officer. “We believe we are well positioned to explore...

Continue reading

GXO Receives SDCE’s 2023 Top Supply Chain Projects Award for State-of-the-Art Automated Returns Operation in the U.S.

Award highlights successful effort to develop and deploy innovative, state-of-the-art automation for an industry-leading consumer electronics company GREENWICH, Conn., June 14, 2023 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has been recognized by Supply & Demand Chain Executive magazine (SDCE) for the second consecutive year for a Top Supply Chain Project. The 2023 award turns the spotlight on a project to develop and deploy innovative, state-of-the-art returns automation for a Fortune 100 telecommunications company. “We’re pleased to be recognized by SDCE for what is one of the most innovative automation solutions for complex, high-value reverse logistics operating in the U.S.,” said Eduardo Pelleissone, President, Americas and Asia...

Continue reading

Nurix Therapeutics Presents Data from Studies of Its Targeted Protein Degraders in B Cell Malignancies and Initiates Expansion of NX-2127 Phase 1b Trial in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma Indications

Initiation of NX-2127 Phase 1b expansion cohort in patients with diffuse large B cell lymphoma (DLBCL) was informed by a rapid and sustained complete response; Phase 1b expansion cohort also initiated in patients with mantle cell lymphoma (MCL) Clinical biomarker data from Phase 1a trial of NX-5948 demonstrate rapid, robust, and sustained degradation of Bruton’s tyrosine kinase (BTK) and support ongoing investigation of B cell malignancies NX-5948 crosses the blood brain barrier and catalyzes robust and efficient degradation of BTK, improving survival in an intracranial patient-cell-derived preclinical model of central nervous system (CNS) lymphoma SAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed...

Continue reading

ArcelorMittal and John Cockerill announce plans to develop world’s first industrial scale low temperature, iron electrolysis plant

Volteron™ plant targeted to start-up in 2027 14 June 2023, 13:00 CET ArcelorMittal, the world’s leading steel company, and John Cockerill, a group leading the development of steel processing facilities and electrolysers, today announce plans to construct the world’s first industrial-scale low temperature, iron electrolysis plant. The Volteron™ plant, which in a first phase will produce between 40,000 and 80,000 tonnes a year of iron plates, is targeted to start production in 2027. Once the technology has been proven at this scale, the intention is to increase the plant’s annual capacity to between 300,000 and 1 million tonnes. ArcelorMittal and John Cockerill have been working together on an innovative electrochemical process to transform iron oxide into iron plates for the last few years. The successfully completed project,...

Continue reading

Plus Therapeutics to Participate in the 2023 Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

AUSTIN, Texas, June 14, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, announced today that Marc Hedrick, M.D., President and Chief Executive Officer, has been invited to participate in a fireside chat at the 2023 Healthcare Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, June 21, 2023 at 3:30 p.m. ET. The conference will take place June 20-22, 2023, and will be hosted live on M-Vest and available under the For Investors tab of the Plus Therapeutics website at www.plustherapeutics.com. To attend virtually, sign up to become an M-Vest member here: Reserve Your Seat. About Plus TherapeuticsPlus Therapeutics, Inc....

Continue reading

Tilray Brands Expands Beer Portfolio and Launches Good Supply Light Beer

Tilray Introduces New Easy-Drinking Light Beer Brand, Good Supply, in the U.S.Good Supply Easy Lager is Perfectly Chilled and Ready for Easy-Drinking Good Supply’s clean taste and premium ingredients are an ode to simplicity, yet not compromising on the things that matter, like selecting the finest Pilsner malts and investing time and thought into perfecting the recipe.ATLANTA, June 14, 2023 (GLOBE NEWSWIRE) — Tilray Brands Inc., (NASDAQ: TLRY and TSX: TLRY) the global cannabis and consumer packaged goods company, today announced the launch of Good Supply Beer, a new light beer brand and premium lager brewed for easy-drinking at a refreshing price. Good Supply beer is now available year-round in 16-ounce cans across Georgia, Connecticut, and New York with added distribution rolling out this summer. Ty Gilmore, President, U.S....

Continue reading

VICTORY DRILLS 137 ft AT 1023 Li PPM, INCLUDING 85 FT AT 1267 Li PPM WITH A HIGH INTERCEPT OF 1620 Li PPM IN ITS 23-01 DRILL HOLE AT ITS SMOKEY LITHIUM, NEVADA PROPERTY

Figure 1 Lithium MineralizationFigure 2 Smokey Lithium Drill Core Lithium Values (2022&2023)VANCOUVER, BC, CANADA, June 14, 2023 (GLOBE NEWSWIRE) —Victory’s exploration team’s analysis of its Phase 2 drill program is highlighted by strong correlations extending the high-grade intercepts from the Phase 1 2022 drill program on its 22-09 and 23-01 holes, featuring higher ppm Li results The drill program included 4 holes, with a combined total of 1966.5 feet of drilling As a result of initial analysis, Victory made the decision to stake 100 new lode claims as announced on 12 June 2023, expanding the property by 2066 acres to 5691 acresVANCOUVER, BC, CANADA (14 June 2023) – Victory Battery Metals (CSE: VR) (FWB: VR6) (OTC: VRCFF) (“Victory” or the “Company”) is excited to announce the drill results from its Phase...

Continue reading

Applied UV’s Subsidiary, LED Supply Co., and Its FORTUNE® 500 Technology Partner Awarded Approximately $0.8 million Contract for Comprehensive Lighting & Building Controls Solution for Global Auto Manufacturer’s U.S. Facility

MOUNT VERNON, NY, June 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Applied UV, Inc. (Nasdaq: AUVI) (“Applied UV” or the  “Company”), a leading provider of advanced food security and air and surface disinfection technology, announces today in collaboration with its FORTUNE® 500 technology partner, it has been awarded a contract valued at approximately $0.8 million. The contract encompasses comprehensive lighting and building controls design for a domestic auto manufacturer’s U.S. facility. This contract is a direct result of the Company’s investment in providing lighting and building solutions for the revival of large manufacturing facilities in the United States as companies return their manufacturing to the U.S. in an effort to mitigate supply chain challenges in importing goods from China. The project represents a significant...

Continue reading

Verano Introduces On The Rocks, New Multi-Format Brand Anchored Around Solventless Extraction Methods, Across Core Markets

On The Rocks offers small batch solventless extracts, including live rosin cartridges, concentrates and gummies, hand-crafted for the most pure and flavorful expression of the plantOn The Rocks™ solventless extracts are developed through dry sifting and ice water extraction methods to capture the essence of cannabis flower by isolating its cannabinoid- and terpene-rich trichomes On The Rocks™ first launched in Pennsylvania earlier this month with Illinois planned for mid-June, followed by Florida, and additional core markets including Arizona and New Jersey in later 2023CHICAGO, June 14, 2023 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of On The Rocks™, a line of small-batch solventless...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.